bpc-157 human trials oral vs injection Heal or Harm: Body Protective Compound-157 in the Gray Zone BPC 157 Oral vs Injection:

Dec 14, 2024 | video In this episode of the Pursuit Podcast we discuss: 1

Research Summary The BPC-157/TB-500/GHK-Cu/KPV peptide blend leverages synergistic mechanisms to promote tissue repair and reduce inflammation, with evidence primarily from preclinical animal models

This includes reduced ability to secrete insulin, heightened insulin resistance, and elevated blood sugar levels, potentially resulting in diminished expression of GLP-1 receptors and developing GLP-1 resistance

Composition : Each ml Bi-12 IV/IM Injection 500 mcg/ml contains Mecobalamin 500 mcg

Safety and efficacy in pediatric populations have not been established